Tag: HMO
-
FSANZ Approves New Source of 2′-Fucosyllactose for Infant Formula: Implications for HMO Suppliers and Manufacturers
Abstract Food Standards Australia New Zealand (FSANZ) has approved Application A1334, permitting the use of 2′-fucosyllactose (2′-FL) produced from a new genetically modified source organism as a nutritive substance in…